Aspirin for the primary prevention of cardiovascular disease: a comprehensive review

Nicolas Rodondi; Jacques Cornuz; Douglas C Bauer

doi:10.1385/comp:31:3:186

Aspirin for the primary prevention of cardiovascular disease: a comprehensive review

Compr Ther. 2005 Fall;31(3):186-93. doi: 10.1385/comp:31:3:186.

Authors

Nicolas Rodondi¹, Jacques Cornuz, Douglas C Bauer

Affiliation

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Nicolas.Rodondi@hospvd.ch

PMID: 16110127
DOI: 10.1385/comp:31:3:186

Abstract

Aspirin use for the primary prevention of cardiovascular disease should be targeted to patients with a high cardiovascular risk. Physicians should assess the risks and benefits of aspirin therapy for primary prevention and incorporate patient preferences.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control*
Cerebral Hemorrhage / etiology
Dose-Response Relationship, Drug
Gastrointestinal Hemorrhage / etiology
Humans
Patient Participation
Primary Prevention*
Risk Assessment

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin